ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1898

Overweight/Obesity Affect Histological Features of Synovial Membrane of Rheumatoid Arthritis Patients from Disease Onset to Stable Remission Achievement

Stefano Alivernini1, Barbara Tolusso1, Maria Rita Gigante1, Laura Bui2, Clara Di Mario1, Luca Petricca1, Gabriele Di Sante1, Roberta Benvenuto2, Anna Laura Fedele1, Francesco Federico2, Gianfranco Ferraccioli3 and Elisa Gremese1, 1Institute of Rheumatology, Fondazione Policlinico Universitario A. Gemelli - Catholic University of the Sacred Heart, Rome, Italy, 2Institute of Pathology, Fondazione Policlinico Universitario A. Gemelli - Catholic University of the Sacred Heart, Rome, Italy, 3Institute of Rheumatology, Università Cattolica - Fondazione Policlinico Universitario A.Gemelli, Rome, Italy

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: obesity, rheumatoid arthritis (RA) and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Rheumatoid Arthritis – Clinical Aspects III: Obesity and Other Comorbidities

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Despite animal models, little is known about synovial tissue (ST) composition of overweight/obese Rheumatoid Arthritis patients. The aim of the study was to investigate the impact of high Body Mass Index (BMI) on ST inflammation of RA patients from disease onset to stable remission achievement.

Methods: One-hundred twenty five RA patients [(57 DMARDs naïve, 43 Methotrexate inadequate responder (MTX-IR) and 25 in stable clinical (DAS<1.6) and ultrasound remission under MTX+TNF-i respectively] were enrolled and underwent ST biopsy. At study entry RA patients were divided based on BMI (kg/m2) in normal weight (BMI<25), overweight (BMI>25) and obese (BMI>30) respectively. Immunohistochemistry for CD68+, CD21+, CD20+ and CD3+ cells was performed. Each naive RA patient was treated according to the treat to target (T2T) strategy and followed for 12 months.

Results: Among the whole RA cohort, naïve RA were younger (53.5 ± 15.4 years) than MTX-IR RA (59.5 ± 13.8 years) and RA patients in stable remission (57.2 ± 15.0; p=0.02 using ANOVA test), whereas there were no significant differences in terms of other demographic, immunological and clinical characteristics comparing naive to treatment and MTX-IR RA patients. The overweight/obesity rate was comparable between the 3 subgroups [34(59.6%) naïve RA vs 25(58.2%) MTX-IR RA vs 14(56.0%) RA in stable remission were overweight/obese, p>0.05]. However, naive RA patients with BMI>30 kg/m2 showed more likely follicular synovitis (78.6%) than normal weight naïve RA (39.1%; p=0.02). Particularly, naive RA with BMI>35kg/m2 showed higher histological scores for CD68+ (p=0.03 and p=0.01 for lining and sublining), sublining CD20+ (p=0.005), CD21+ (p<0.001 and p=0.003 for lining and sublining) and sublining CD3+ cells (p=0.003) than normal weight naïve RA. Moreover, BMI directly correlated with synovial aggregate grade (R=0.311; p=0.02) and histological scores of CD21+ (R=0.344; p=0.01), CD20+ (R=0.295; p=0.03) and CD3+ cells (R=0.256; p=0.05) in naive RA. Conversely, MTX-IR RA patients showed similar synovial inflammation degree based on different BMI categories. Regardless of the synovial inflammatory pattern (follicular vs diffuse), naive overweight/obese RA patients showed a worse clinical response to T2T strategy compared to normal weight naive RA at 6 and 12 months follow-up respectively (p<0.05 for both). Finally, despite RA in stable remission showed lower disease activity index (DAS) and inflammatory markers (ESR and CRP) than naïve RA (p<0.001 for each comparison), overweight/obese RA in stable remission showed higher degree of residual synovial inflammation in terms of sublining CD68+ cells (p=0.001), lining CD20+ cells (p=0.04), and lining and sublining CD3+ cells (p=0.04 and p=0.05 respectively) compared to normal weight RA patients in stable remission.

Conclusion: Overweight and obesity are associated with higher degree of histologically proven synovitis in RA patients from the time of disease onset to the achievement of stable remission influencing the response rate to T2T regimen. These findings suggest that BMI control should be a key target during the whole disease course in RA patients.


Disclosure: S. Alivernini, None; B. Tolusso, None; M. R. Gigante, None; L. Bui, None; C. Di Mario, None; L. Petricca, None; G. Di Sante, None; R. Benvenuto, None; A. L. Fedele, None; F. Federico, None; G. Ferraccioli, None; E. Gremese, None.

To cite this abstract in AMA style:

Alivernini S, Tolusso B, Gigante MR, Bui L, Di Mario C, Petricca L, Di Sante G, Benvenuto R, Fedele AL, Federico F, Ferraccioli G, Gremese E. Overweight/Obesity Affect Histological Features of Synovial Membrane of Rheumatoid Arthritis Patients from Disease Onset to Stable Remission Achievement [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/overweightobesity-affect-histological-features-of-synovial-membrane-of-rheumatoid-arthritis-patients-from-disease-onset-to-stable-remission-achievement/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/overweightobesity-affect-histological-features-of-synovial-membrane-of-rheumatoid-arthritis-patients-from-disease-onset-to-stable-remission-achievement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology